FXR1 Antibodies

Santa Cruz Biotechnology provides a broad selection of FXR1 monoclonal antibodies for research focused on understanding FXR1 protein functions. The monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). FXR1, or Fragile X Mental Retardation 1, belongs to the fragile X family of proteins and serves essential functions in RNA metabolism and cellular processes. FXR1 actively participates in regulating gene expression and has significant implications in neurodevelopmental disorders. Understanding FXR1 function is crucial for uncovering molecular mechanisms involved in fragile X syndrome and related conditions. Research focusing on FXR1 continues to reveal new insights into cognitive function and disease progression. Investigating FXR1 helps advance our understanding of RNA-binding protein functions in cellular development and regulation. Current studies highlight FXR1's role in various biological pathways and disease mechanisms. Santa Cruz Biotechnology monoclonal antibodies enable researchers worldwide to advance scientific understanding of FXR1's role in health and disease.